Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TELBIVUDINE for Chronic hepatitis b: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 153 adverse event reports in the FDA FAERS database where TELBIVUDINE was used for Chronic hepatitis b.

Most Reported Side Effects for TELBIVUDINE

Side Effect Reports % Deaths Hosp.
Drug resistance 103 23.7% 0 10
Blood creatine phosphokinase increased 84 19.4% 2 43
Foetal exposure during pregnancy 58 13.4% 13 3
Myalgia 49 11.3% 2 22
Drug ineffective 37 8.5% 0 6
Pathogen resistance 37 8.5% 0 6
Muscular weakness 33 7.6% 1 19
Maternal exposure during pregnancy 31 7.1% 0 3
Treatment failure 31 7.1% 0 0
Asthenia 26 6.0% 3 18
Viral mutation identified 25 5.8% 0 0
Rhabdomyolysis 24 5.5% 3 12
Hepatic cirrhosis 20 4.6% 5 16
Myopathy 20 4.6% 0 12
Vomiting 20 4.6% 5 14

Other Indications for TELBIVUDINE

Hepatitis b (111) Product used for unknown indication (52) Foetal exposure during pregnancy (30) Hiv infection (20) Hepatic cirrhosis (12) Antiviral treatment (11) Viral infection (9) Hepatitis viral (8)

Other Drugs Used for Chronic hepatitis b

TENOFOVIR DISOPROXIL (1,156) LAMIVUDINE (998) ADEFOVIR DIPIVOXIL (776) ENTECAVIR (705) TENOFOVIR ALAFENAMIDE (679) PEGINTERFERON ALFA-2A (234) TENOFOVIR (187) ADEFOVIR (77) EMTRICITABINE\TENOFOVIR DISOPROXIL (34) PEGINTERFERON ALFA-2B (32)

Related Pages

TELBIVUDINE Full Profile All Chronic hepatitis b Drugs TELBIVUDINE Demographics TELBIVUDINE Timeline